ANIK - Anika Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5507.07M
Enterprise Value 3426.55M
Trailing P/E 28.01
Forward P/E 123.95
PEG Ratio (5 yr expected) 13.68
Price/Sales (ttm)4.70
Price/Book (mrq)1.99
Enterprise Value/Revenue 33.95
Enterprise Value/EBITDA 612.77

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018

Profitability

Profit Margin 17.66%
Operating Margin (ttm)25.85%

Management Effectiveness

Return on Assets (ttm)6.43%
Return on Equity (ttm)7.50%

Income Statement

Revenue (ttm)107.99M
Revenue Per Share (ttm)7.43
Quarterly Revenue Growth (yoy)-1.50%
Gross Profit (ttm)86.06M
EBITDA 33.41M
Net Income Avi to Common (ttm)19.07M
Diluted EPS (ttm)1.27
Quarterly Earnings Growth (yoy)10.30%

Balance Sheet

Total Cash (mrq)149.01M
Total Cash Per Share (mrq)10.48
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)21.02
Book Value Per Share (mrq)17.96

Cash Flow Statement

Operating Cash Flow (ttm)31.89M
Levered Free Cash Flow (ttm)25.25M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.69
52-Week Change 3-33.71%
S&P500 52-Week Change 35.47%
52 Week High 369.81
52 Week Low 328.54
50-Day Moving Average 339.75
200-Day Moving Average 339.37

Share Statistics

Avg Vol (3 month) 390.43k
Avg Vol (10 day) 3111.32k
Shares Outstanding 514.21M
Float 13.86M
% Held by Insiders 12.37%
% Held by Institutions 199.75%
Shares Short (Oct 31, 2018) 42.22M
Short Ratio (Oct 31, 2018) 423.88
Short % of Float (Oct 31, 2018) 422.00%
Short % of Shares Outstanding (Oct 31, 2018) 415.65%
Shares Short (prior month Sep 28, 2018) 42.47M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A